The effect of high-dose Levothyroxine on hearing in patients operated for thyroid cancer.

Vahit MutluZülküf KayaArzu BilenRamazan Dayanan

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)

In our study, we found that patients taking 150 µg or more of L-T4 daily were more osteopenic and osteoporotic and had more hearing loss in both ears.

Keyphrases

end stage renal disease
high dose
ejection fraction
chronic kidney disease
hearing loss
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported